44:04
Dr. Whitfield's Answer
Dr. Meg Mill joins Dr. Whitfield for a clinical deep-dive into diagnosing and treating Mast Cell Activation Syndrome in women with breast implant illness. They discuss testing protocols, treatment strategies, and the connection between implants and immune dysfunction.
Key Takeaways
- 1MCAS is frequently underdiagnosed in women with breast implant illness
- 2Tryptase and histamine metabolite testing are key diagnostic markers
- 3A multi-system approach combining explant with mast cell stabilization yields the best outcomes
- 4Environmental triggers including mold and toxins can compound MCAS symptoms in implant patients